Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Milestone Pharmaceuticals

NASDAQ MIST
$1.75 0.0050 0.29%
Today share price
Canada
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 17 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

87.27M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
123.83M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
3.75
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
50.16M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
4.19 %

Upcoming events Milestone Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Milestone Pharmaceuticals

Stock analysis Milestone Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-1.58 28.88
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
5.20 4.03
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-2.23 11.32
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-0.66 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-138.00 10.75

Price change Milestone Pharmaceuticals per year

5.09$ 9.03$
Min Max

Summary analysis Milestone Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Milestone Pharmaceuticals

Revenue and net income Milestone Pharmaceuticals

All parameters

Stock news Milestone Pharmaceuticals

All news
29 February в 18:35

Milestone Pharmaceuticals Shares Fall Premarket After Stock Offering

26 December 2023 в 16:30

Milestone Pharmaceuticals Shares Sink 24% After Receiving Rejection from FDA

26 December 2023 в 16:30

Milestone Pharmaceuticals Shares Sink 24% After Receiving Rejection from FDA

26 December 2023 в 15:35

Milestone Pharmaceuticals' Etripamil Nasal Spray Application Gets FDA's Refusal to File Letter

26 December 2023 в 15:35

Milestone Pharmaceuticals' Etripamil Nasal Spray Application Gets FDA's Refusal to File Letter

28 March 2023 в 17:30

Milestone Pharmaceuticals Shares Rise 15% After Funding Agreement

28 March 2023 в 17:30

Milestone Pharmaceuticals Shares Rise 15% After Funding Agreement

17 October 2022 в 19:20

Milestone Pharmaceuticals Shares Reverse Course, Fall 8.7%

17 October 2022 в 19:20

Milestone Pharmaceuticals Shares Reverse Course, Fall 8.7%

17 October 2022 в 13:31

Milestone Pharmaceuticals Sees Positive Results in Etripamil Trial

17 October 2022 в 13:31

Milestone Pharmaceuticals Sees Positive Results in Etripamil Trial

17 October 2022 в 13:26

Milestone Pharmaceuticals Sees Positive Results in Etripamil Trial

17 October 2022 в 13:26

Milestone Pharmaceuticals Sees Positive Results in Etripamil Trial

About company Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as in the Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate, and other cardiovascular indications. Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil in patients with paroxysmal supraventricular tachycardia and additional cardiovascular conditions in Greater China. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
Address:
1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
Company name: Milestone Pharmaceuticals
Issuer ticker: MIST
ISIN: CA59935V1076
Country: Canada
Exchange: NASDAQ
Currency: $
IPO date: 2019-05-09
Sector: Healthcare
Industry: Biotechnology
Site: https://www.milestonepharma.com

On which stock exchange are Milestone Pharmaceuticals (MIST) stocks traded?

Milestone Pharmaceuticals (MIST) stocks are traded on NASDAQ.

What is the ticker of Milestone Pharmaceuticals stocks (MIST)?

The stock ticker of Milestone Pharmaceuticals’s stocks or in other words, the code is MIST. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Milestone Pharmaceuticals (MIST) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Milestone Pharmaceuticals (MIST) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Milestone Pharmaceuticals (MIST) stocks traded?

Milestone Pharmaceuticals (MIST) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Milestone Pharmaceuticals (MIST) stocks today?

The current price of Milestone Pharmaceuticals stocks on 21.05.2024 is 1.745 dollars. per share.

What is the dynamics of Milestone Pharmaceuticals (MIST) stocks from the beginning of the year?

Milestone Pharmaceuticals (MIST) quotes have increased by -3.06% from the beginning of the year up to 1.745 dollars. per 1 stocks.

How much did Milestone Pharmaceuticals (MIST) stocks increase in мае 2024?

This month Milestone Pharmaceuticals (MIST) quotes have increased by 9.06% to 1.745 dollars. per share.

How much are Milestone Pharmaceuticals (MIST) stocks worth?

Today, on October, 21.05.2024 Milestone Pharmaceuticals’s (MIST) stocks cost 1.745 dollars..

What is the market capitalization of Milestone Pharmaceuticals (MIST)?

Capitalization is the market value of Milestone Pharmaceuticals (MIST) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 21.05.2024, the market capitalization of Milestone Pharmaceuticals (MIST) is estimated at about 87269893 dollars.